Article Link: FDA Approves Amgen’s Parsabiv (etelcalcetide) for Secondary Hyperparathyroidism in Adult Patients on Hemodialysis �...

Article Link: Teva Announces FDA Approval of ArmonAir RespiClick (fluticasone propionate) for Maintenance Treatment of Asthma
...

Article Link: Teva Announces FDA Approval of AirDuo RespiClick (fluticasone propionate and salmeterol) for Maintenance Treatment of Asthma ...

Article Link: Sunovion’s Latuda (lurasidone) Receives FDA Approval to Treat Adolescents with Schizophrenia Source: FDA New ...

Article Link: U.S. FDA Approves 72 mcg Dose of Linzess (linaclotide) for Adults with Chronic Idiopathic Constipation Source...

Article Link: Symbicort Approved for the Treatment of Asthma in Patients 6 to 12 Years of Age Source: FDA New Drug Approval...

Article Link: FDA Approves Arymo ER (morphine sulfate) Abuse-Deterrent Formulation for the Treatment of Chronic Pain Source...

Article Link: FDA Approves Genentech’s Lucentis (ranibizumab) for Myopic Choroidal Neovascularization Source: FDA New Drug ...

Article Link: Shire Announces FDA Approval of Adynovate [Antihemophilic Factor (Recombinant), PEGylated] for Use in Children and Surgical Settings
...

Article Link: FDA Approves Spinraza (nusinersen) for Spinal Muscular Atrophy Source: FDA New Drug Approvals